| Literature DB >> 10753539 |
I Woltsche-Kahr1, P Komericki, B Kränke, E Brabek, M Horn, S Schuller-Petrovic, E Richtig, W Aberer.
Abstract
Recently, sentinel lymph node dissection has been established for early staging of malignant melanoma. We describe an anaphylactic reaction due to patent blue injection in sentinel lymph node procedure, which was proven by positive results in intradermal testing with patent blue 1:100. Copyright 2000 Harcourt Publishers Ltd.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10753539 DOI: 10.1053/ejso.1999.0888
Source DB: PubMed Journal: Eur J Surg Oncol ISSN: 0748-7983 Impact factor: 4.424